Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device

PHASE3CompletedINTERVENTIONAL
Enrollment

488

Participants

Timeline

Start Date

February 28, 2007

Study Completion Date

September 30, 2007

Conditions
Angioplasty, Transluminal, Percutaneous CoronaryCoronary ArteriosclerosisPeripheral Arteriosclerosis
Interventions
OTHER

Manual Compression

Manual compression

DEVICE

Vascular Closure Device

Investigational vascular closure device

Trial Locations (17)

10021

New York Presbyterian Hospital - Cornell Medical College of Cornell University, New York

13088

SJH Cardiology Associates, Liverpool

17043

Moffitt Heart & Vascular Group, Wormleysburg

19102

Hahnemann Hospital, Philadelphia

27610

Wake Heart Research, Raleigh

33756

Morton Plant Hosptial, Clearwater

44122

University Hospitals of Cleveland, Cleveland

46290

The Care Group, Indianapolis

63110

Washington University School of Medicine at Barnes-Jewish Hospital, St Louis

75226

Baylor Research Institute, Dallas

84143

LDS Hospital, Salt Lake City

85054

Mayo Clinic Hospital, Phoenix

95817

University of California Davis Medical Center, Sacramento

95819

Sutter Memorial Hospital, Sacramento

98117

Swedish Medical Center, Seattle

94305-5218

Stanford University, Stanford

08103

Cooper Health Systems, Camden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cordis Corporation

INDUSTRY

NCT00345631 - Safety and Effectiveness Study of the Ensure Medical Vascular Closure Device | Biotech Hunter | Biotech Hunter